Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-Dose Lomitapide for Hepatic Fat in Hyperlipidemia
NCT00559962Phase 2Completed
- Sponsor
- Aegerion Pharmaceuticals
- Start
- Oct 2007
- Primary completion
- Oct 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lomitapide in hyperlipidemia, sponsored by Aegerion Pharmaceuticals. Started Oct 2007; status: completed.
02
Drugs
lomitapide
03
Conditions
hyperlipidemia
Beyond the preview
Go deeper on NCT00559962.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00559962.